To avoid embryo-fetal exposure, REVLIMID® is only available through a restricted distribution program called a Risk Evaluation and Mitigation Strategies (REMS). The REVLIMID REMS® program requires prescribers and pharmacies to be certified and patients to enroll and comply with all of the program requirements. For more information about the REVLIMID REMS® program, please visit www.CelgeneRiskManagement.com or call 1-888-423-5436.
Your Celgene Patient Support® Specialist can provide information on which pharmacy is in-network with your insurer.
How can I get more information about REVLIMID®?
Your healthcare team is the best source of information. However, if you want to learn more about getting started with REVLIMID®, you can go directly to the REVLIMID® website at www.REVLIMID.com.
REVLIMID® (lenalidomide) is only available through a restricted distribution program called REVLIMID REMS®.
Please see full Prescribing Information, including Boxed WARNINGS, for REVLIMID®.
Your Specialist is assigned based on the zip code of your doctor’s office. To meet your Specialist, enter the zip code of your doctor’s office below.
This website is intended for
US healthcare professionals only
The ICD-10-CM Codes provided here are for diagnoses reasonably related to an indication or indications within the product’s approved label and are provided for your reference only. Other codes may be appropriate. Celgene makes no representation that any code is appropriate for a particular patient. Healthcare Professionals must use their independent judgment in selecting Code(s) to accurately reflect the diagnosis of the specific patient.